Emerald Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Sell |
|
|||||
|
2025
Q1 | $13.6M | Sell |
|
|||||
|
2024
Q4 | $15.1M | Sell |
|
|||||
|
2024
Q3 | $12.8M | Buy |
|
|||||
|
2024
Q2 | $13.1M | Sell |
|
|||||
|
2024
Q1 | $30.5M | Buy |
|
|||||
|
2023
Q4 | $51.5M | Sell |
|
|||||
|
2023
Q3 | $35M | Buy |
|
|||||
|
2023
Q2 | $38.7M | Buy |
|
|||||
|
2023
Q1 | $28.2M | Buy |
|
|||||
|
2022
Q4 | $21M | Sell |
|
|||||
|
2022
Q3 | $21.8M | Buy |
|
|||||
|
2022
Q2 | $12.1M | Buy |
|
|||||
|
2022
Q1 | $19.1M | Buy |
|
|||||
|
2021
Q4 | $16.7M | Buy |
|